Pharmacovigilance Professional with 2 years of experience in capturing and assessing single adverse event reports associated with client products on a worldwide basis on the client's drug safety database, in accordance with international and local regulatory requirements. To seek and maintain full-time position that offers professional challenges utilizing interpersonal skills, excellent time management and problem-solving skills.
GPA: 7.02, Major Project – “Bioequivalence Study of Pramipexole Dihydrochloride Monohydrate 0.18 Mg Tablet Versus „Sifrol, 18 Mg Tablets in Healthy Adult Subjects Under Fasting Conditions: A Randomized, Open-Label, Two-Way Crossover Study” Major Project Advisor – Prof. Dr. Rahul Desmukh
Marks: 78.80%
Marks: 74%
ICH Guidelines
undefined14Th International Conferences on Pharmaceutics and Drug Safety” held during Aug 06-07, 2021 at London UK
14Th International Conferences on Pharmaceutics and Drug Safety” held during Aug 06-07, 2021 at London UK
“Series of Recombinant DNA Technology Webinar Series” in May – Jun 2020 by Merck Innovation lab
Prophylaxis Management” Organized by ISF College of Pharmacy (An Autonomous College), Moga
Participated in ISFCON – 2020: “International Conference on Covid-19: Challenges in Testing